Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Some of you are trying to reframe this discussion about marginalizing TPL
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Well said. I too believe that the BoD and shareholders are now on the same page regarding TPL and Alliacense. I also agree with you when you said : " Any "inhouse" disagreements we have with the BOD are different, and in fact, I fully expect that quite a few of those differences would be eliminated should we gain operational and licensing control of the MMP portfolio"

Shareholders are watching and waiting for a response from Cliff, Gloria and Carl.

9 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply